Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play OutSeeking Alpha • 04/09/25
Investing in Perrigo (PRGO)? Don't Miss Assessing Its International Revenue TrendsZacks Investment Research • 03/05/25
Do You Own 15 Stocks Morningstar Calls The Top 'Wealth Destroyers?'Investors Business Daily • 03/03/25
Perrigo Provides Detailed Plan to Consumerize, Simplify and Scale its Unique Global Self-Care Platform at its Virtual Investor DayPRNewsWire • 02/28/25
Perrigo (PRGO) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 02/28/25
Perrigo Reports Fourth Quarter & Fiscal Year 2024 Financial Results From Continuing OperationsPRNewsWire • 02/27/25
Countdown to Perrigo (PRGO) Q4 Earnings: A Look at Estimates Beyond Revenue and EPSZacks Investment Research • 02/25/25
Opill® extends mission of breaking down birth control barriers with launch of multi-state college tour and expansion of partnershipsPRNewsWire • 02/04/25
Perrigo to Release Fourth Quarter and Fiscal Year 2024 Financial Results on February 27, 2025, Host Virtual Investor Day on February 28, 2025PRNewsWire • 01/31/25
Perrigo Expands its Scientific Office; Appoints Abbie Lennox as Executive Vice President and Chief Scientific OfficerPRNewsWire • 01/06/25
Perrigo (PRGO) Up 5.6% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 12/09/24